These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6433080)

  • 21. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.
    Kline WE
    Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834
    [No Abstract]   [Full Text] [Related]  

  • 22. [Selection of donors in the prevention of post-transfusion viral hepatitis].
    Massaro AL
    Riv Emoter Immunoematol; 1985; 32(2):156-9. PubMed ID: 3937210
    [No Abstract]   [Full Text] [Related]  

  • 23. [Route of transmission and prevention of non-A, non-B hepatitis].
    Iino S
    Nihon Rinsho; 1988 Dec; 46(12):2729-34. PubMed ID: 3149346
    [No Abstract]   [Full Text] [Related]  

  • 24. [Guanine deaminase and adenosine deaminase activity in chronic glomerulonephritis].
    Burian AE; Fedorov NA
    Klin Med (Mosk); 1980 Dec; 58(12):92-5. PubMed ID: 7206625
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis].
    Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M
    Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897
    [No Abstract]   [Full Text] [Related]  

  • 26. [Screening of blood donors for the prevention of non-A, non-B hepatitis].
    Seidl S
    Dtsch Med Wochenschr; 1983 Jan; 108(4):123-4. PubMed ID: 6402351
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical significance of serum guanine deaminase in hepatic diseases].
    Nishikawa Y; Suganuma H; Oki Y; Watanabe F
    Rinsho Byori; 1982 Nov; 30(11):1241-5. PubMed ID: 7182597
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of serum guanase activity in liver diseases.
    Nishikawa Y; Fukumoto K; Watanabe F
    Clin Biochem; 1984 Oct; 17(5):327-30. PubMed ID: 6499163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serum guanase activity in rabbits during toxic liver damage].
    Prokopowicz D; Miegoć H; Jarocki F; Wasilewski J
    Z Versuchstierkd; 1980; 22(4):211-5. PubMed ID: 7467891
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum guanase: a biochemical indicator of rejection in liver transplant recipients.
    Crary GS; Yasmineh WG; Snover DC; Vine W
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2315-6. PubMed ID: 2652749
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of guanase by agarose gel electrophoresis].
    Nishikawa Y; Fukumoto K; Watanabe F
    Rinsho Byori; 1986 May; 34(5):595-9. PubMed ID: 3761627
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of post-transfusional hepatitis].
    Hernández JM
    Sangre (Barc); 1988 Jun; 33(3):242. PubMed ID: 3140399
    [No Abstract]   [Full Text] [Related]  

  • 34. Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis.
    Lenes BA; Tomasulo P; Alter HJ; Holland PV
    N Engl J Med; 1983 Mar; 308(12):723. PubMed ID: 6402702
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical value of the determination of serum guanase activity. Studies on patients and experimental data from mongrel dogs and cultured rat hepatocytes.
    Ito S; Takaoka T; Nakaya Y; Hiasa Y; Mori H; Tanaka K; Ichihara A
    Gastroenterology; 1982 Nov; 83(5):1102-8. PubMed ID: 6288507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Public Health Council advisory: prevention of post-transfusion non-A non-B hepatitis; is application of a surrogate test a missed station?].
    Brandt KH
    Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2212-4. PubMed ID: 2509949
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the diagnostic value of various enzymatic activties in icterogenic hepatitis of infancy. II. Sorbitol dehydrogenase, guanase and argininosuccinate lyase].
    Rossi R; Caldini M; Cocchi R
    Quad Sclavo Diagn; 1975 Dec; 11(4):720-34. PubMed ID: 1232640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic measurement of guanine deaminase in serum with a centrifugal analyzer.
    Nishikawa Y; Fukumoto K
    Clin Chem; 1981 Apr; 27(4):560-1. PubMed ID: 7471421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contributions to the optimal use of human blood. IX. Elimination of hepatitis B transmission by (potentially) infectious plasma derivatives.
    Stephan W
    Vox Sang; 1984; 46(6):421. PubMed ID: 6431692
    [No Abstract]   [Full Text] [Related]  

  • 40. A sensitive new method for measurement of guanase with 8-azaguanine in bicine bis-hydroxy ethyl glycine buffer as substrate.
    Ito S; Takaoka T; Mori H; Teruo A
    Clin Chim Acta; 1981 Sep; 115(2):135-44. PubMed ID: 7285360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.